BACKGROUND: Cardiovascular disease is a leading cause of death worldwide. Arrhythmias are associated with significant morbidity and mortality related to cardiovascular disease. Recent work illustrates that many cardiac arrhythmias are initiated by a pathologic imbalance between kinase and phosphatase activities in excitable cardiomyocytes. OBJECTIVE: To test the relationship between myocyte kinase/phosphatase imbalance and cellular and whole animal arrhythmia phenotypes associated with ankyrin-B cardiac syndrome. METHODS: By using a combination of biochemical, electrophysiological, and in vivo approaches, we tested the ability of calcium/calmodulin-dependent kinase (CaMKII) inhibition to rescue imbalance in kinase/phosphatase pathways associated with human ankyrin-B-associated cardiac arrhythmia. RESULTS: The cardiac ryanodine receptor (RyR(2)), a validated target of kinase/phosphatase regulation in myocytes, displays abnormal CaMKII-dependent phosphorylation (pS2814 hyperphosphorylation) in ankyrin-B(+/-) heart. Notably, RyR(2) dysregulation is rescued in myocytes from ankyrin-B(+/-) mice overexpressing a potent CaMKII-inhibitory peptide (AC3I), and aberrant RyR(2) open probability observed in ankyrin-B(+/-) hearts is normalized by treatment with the CaMKII inhibitor KN-93. CaMKII inhibition is sufficient to rescue abnormalities in ankyrin-B(+/-) myocyte electrical dysfunction including cellular afterdepolarizations, and significantly blunts whole animal cardiac arrhythmias and sudden death in response to elevated sympathetic tone. CONCLUSIONS: These findings illustrate the complexity of the molecular components involved in human arrhythmia and define regulatory elements of the ankyrin-B pathway in pathophysiology. Furthermore, the findings illustrate the potential impact of CaMKII inhibition in the treatment of a congenital form of human cardiac arrhythmia.
BACKGROUND:Cardiovascular disease is a leading cause of death worldwide. Arrhythmias are associated with significant morbidity and mortality related to cardiovascular disease. Recent work illustrates that many cardiac arrhythmias are initiated by a pathologic imbalance between kinase and phosphatase activities in excitable cardiomyocytes. OBJECTIVE: To test the relationship between myocyte kinase/phosphatase imbalance and cellular and whole animal arrhythmia phenotypes associated with ankyrin-Bcardiac syndrome. METHODS: By using a combination of biochemical, electrophysiological, and in vivo approaches, we tested the ability of calcium/calmodulin-dependent kinase (CaMKII) inhibition to rescue imbalance in kinase/phosphatase pathways associated with humanankyrin-B-associated cardiac arrhythmia. RESULTS: The cardiac ryanodine receptor (RyR(2)), a validated target of kinase/phosphatase regulation in myocytes, displays abnormal CaMKII-dependent phosphorylation (pS2814 hyperphosphorylation) in ankyrin-B(+/-) heart. Notably, RyR(2) dysregulation is rescued in myocytes from ankyrin-B(+/-) mice overexpressing a potent CaMKII-inhibitory peptide (AC3I), and aberrant RyR(2) open probability observed in ankyrin-B(+/-) hearts is normalized by treatment with the CaMKII inhibitor KN-93. CaMKII inhibition is sufficient to rescue abnormalities in ankyrin-B(+/-) myocyte electrical dysfunction including cellular afterdepolarizations, and significantly blunts whole animal cardiac arrhythmias and sudden death in response to elevated sympathetic tone. CONCLUSIONS: These findings illustrate the complexity of the molecular components involved in humanarrhythmia and define regulatory elements of the ankyrin-B pathway in pathophysiology. Furthermore, the findings illustrate the potential impact of CaMKII inhibition in the treatment of a congenital form of humancardiac arrhythmia.
Authors: Ralph J van Oort; Mark D McCauley; Sayali S Dixit; Laetitia Pereira; Yi Yang; Jonathan L Respress; Qiongling Wang; Angela C De Almeida; Darlene G Skapura; Mark E Anderson; Donald M Bers; Xander H T Wehrens Journal: Circulation Date: 2010-11-15 Impact factor: 29.690
Authors: Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-02-23 Impact factor: 29.690
Authors: Shane R Cunha; Thomas J Hund; Seyed Hashemi; Niels Voigt; Na Li; Patrick Wright; Olha Koval; Jingdong Li; Hjalti Gudmundsson; Richard J Gumina; Matthias Karck; Jean-Jacques Schott; Vincent Probst; Herve Le Marec; Mark E Anderson; Dobromir Dobrev; Xander H T Wehrens; Peter J Mohler Journal: Circulation Date: 2011-08-22 Impact factor: 29.690
Authors: Xander H T Wehrens; Stephan E Lehnart; Steven Reiken; John A Vest; Anetta Wronska; Andrew R Marks Journal: Proc Natl Acad Sci U S A Date: 2006-01-06 Impact factor: 11.205
Authors: Yuejin Wu; Zhan Gao; Biyi Chen; Olha M Koval; Madhu V Singh; Xiaoqun Guan; Thomas J Hund; William Kutschke; Satyam Sarma; Isabella M Grumbach; Xander H T Wehrens; Peter J Mohler; Long-Sheng Song; Mark E Anderson Journal: Proc Natl Acad Sci U S A Date: 2009-03-10 Impact factor: 11.205
Authors: Dmitry Terentyev; Andriy E Belevych; Radmila Terentyeva; Mickey M Martin; Geraldine E Malana; Donald E Kuhn; Maha Abdellatif; David S Feldman; Terry S Elton; Sandor Györke Journal: Circ Res Date: 2009-01-08 Impact factor: 17.367
Authors: Solena Le Scouarnec; Naina Bhasin; Claude Vieyres; Thomas J Hund; Shane R Cunha; Olha Koval; Celine Marionneau; Biyi Chen; Yuejin Wu; Sophie Demolombe; Long-Sheng Song; Hervé Le Marec; Vincent Probst; Jean-Jacques Schott; Mark E Anderson; Peter J Mohler Journal: Proc Natl Acad Sci U S A Date: 2008-10-01 Impact factor: 11.205
Authors: Peter J Mohler; Ilaria Rivolta; Carlo Napolitano; Guy LeMaillet; Stephen Lambert; Silvia G Priori; Vann Bennett Journal: Proc Natl Acad Sci U S A Date: 2004-12-03 Impact factor: 11.205
Authors: Roseanne M Wolf; Patric Glynn; Seyed Hashemi; Keyan Zarei; Colleen C Mitchell; Mark E Anderson; Peter J Mohler; Thomas J Hund Journal: Am J Physiol Heart Circ Physiol Date: 2013-02-22 Impact factor: 4.733
Authors: Jerry Curran; Michael A Makara; Sean C Little; Hassan Musa; Bin Liu; Xiangqiong Wu; Iuliia Polina; Joseph S Alecusan; Patrick Wright; Jingdong Li; George E Billman; Penelope A Boyden; Sandor Gyorke; Hamid Band; Thomas J Hund; Peter J Mohler Journal: Circ Res Date: 2014-04-23 Impact factor: 17.367
Authors: Sakima A Smith; Amy C Sturm; Jerry Curran; Crystal F Kline; Sean C Little; Ingrid M Bonilla; Victor P Long; Michael Makara; Iuliia Polina; Langston D Hughes; Tyler R Webb; Zhiyi Wei; Patrick Wright; Niels Voigt; Deepak Bhakta; Katherine G Spoonamore; Chuansheng Zhang; Raul Weiss; Philip F Binkley; Paul M Janssen; Ahmet Kilic; Robert S Higgins; Mingzhai Sun; Jianjie Ma; Dobromir Dobrev; Mingjie Zhang; Cynthia A Carnes; Matteo Vatta; Matthew N Rasband; Thomas J Hund; Peter J Mohler Journal: Circulation Date: 2015-01-28 Impact factor: 29.690
Authors: Sean T DeGrande; Sean C Little; Derek J Nixon; Patrick Wright; Jedidiah Snyder; Wen Dun; Nathaniel Murphy; Ahmet Kilic; Robert Higgins; Philip F Binkley; Penelope A Boyden; Cynthia A Carnes; Mark E Anderson; Thomas J Hund; Peter J Mohler Journal: J Biol Chem Date: 2012-11-30 Impact factor: 5.157
Authors: Jerry Curran; Hassan Musa; Crystal F Kline; Michael A Makara; Sean C Little; John D Higgins; Thomas J Hund; Hamid Band; Peter J Mohler Journal: J Biol Chem Date: 2015-03-30 Impact factor: 5.157
Authors: Patric Glynn; Hassan Musa; Xiangqiong Wu; Sathya D Unudurthi; Sean Little; Lan Qian; Patrick J Wright; Przemyslaw B Radwanski; Sandor Gyorke; Peter J Mohler; Thomas J Hund Journal: Circulation Date: 2015-07-17 Impact factor: 29.690